LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK

Like
Comment
Favorite

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK

TIPRANKS01-09 01:00

Austin, Texas, United States, January 8th, 2026, FinanceWire LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collabo...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2602915053?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-09 01:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602915053","market":"nz","top_or_hot":-1,"title":"LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK","media":"TIPRANKS","content":"<div>\n<p>Austin, Texas, United States, January 8th, 2026, FinanceWire LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collabo...</p>\n\n<a href=\"https://www.tipranks.com/news/newswire/lixte-biotechnology-holdings-nasdaq-lixt-expands-ovarian-cancer-trial-with-md-anderson-and-gsk?utm_source=itigerup.com&utm_medium=referral\">Source Link</a>\n\n</div>\n","source":"tipranks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-09 01:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.tipranks.com/news/newswire/lixte-biotechnology-holdings-nasdaq-lixt-expands-ovarian-cancer-trial-with-md-anderson-and-gsk?utm_source=itigerup.com&utm_medium=referral><strong>TIPRANKS</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Austin, Texas, United States, January 8th, 2026, FinanceWire LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collabo...</p>\n\n<a href=\"https://www.tipranks.com/news/newswire/lixte-biotechnology-holdings-nasdaq-lixt-expands-ovarian-cancer-trial-with-md-anderson-and-gsk?utm_source=itigerup.com&utm_medium=referral\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QLD","symbol_name":"2倍做多纳斯达克100指数ETF-ProShares","start_time":0,"source_url":"https://www.tipranks.com/news/newswire/lixte-biotechnology-holdings-nasdaq-lixt-expands-ovarian-cancer-trial-with-md-anderson-and-gsk?utm_source=itigerup.com&utm_medium=referral","article_id":"2602915053","we_media_id":null,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/lixte-biotechnology-holdings-nasdaq-lixt-expands-ovarian-cancer-trial-with-md-anderson-and-gsk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2602915053","pubTimestamp":1767891614,"columns":[],"sourceInfo":{"source_id":"tipranks_highlight","name":"Tipranks"},"weMediaInfo":null,"summary":"Austin, Texas, United States, January 8th, 2026, FinanceWire LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collabo...","collect":0,"end_time":0,"defaultTopTitle":"tipranks.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"QLD":"2倍做多纳斯达克100指数ETF-ProShares","BK4532":"文艺复兴科技持仓","USJW.SI":"ALPHAB 3xLongSG261006","SQQQ":"纳指三倍做空ETF","MD":"Pediatrix Medical","BK4585":"ETF&股票定投概念",".IXIC":"NASDAQ Composite","TSYW.SI":"TESLA 3xLongSG261006","BK4139":"生物科技","QID":"两倍做空纳斯达克指数ETF-ProShares","USAW.SI":"AMZN 3xLongSG261006","GSK.UK":"葛兰素史克","TQQQ":"纳指三倍做多ETF","GSK":"葛兰素史克","LIXT":"Lixte Biotechnology Holdings Inc.","BK4588":"碎股","PSQ":"做空纳斯达克100指数ETF-ProShares","BK4007":"制药","BK4196":"保健护理服务","LU1829250122.USD":"高盛欧洲核心股票组合Acc","NVIW.SI":"NVDA 3xLongSG261006"},"translate_title":"LIXTE Biotechnology Holdings（纳斯达克：LIXT）与MD Anderson和GSK扩大卵巢癌试验","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GSK.UK":0.6,"MNQmain":0.6,"USAW.SI":0.6,"SQQQ":0.6,"QID":0.6,"LIXT":1.5,"TSYW.SI":0.6,"TQQQ":0.6,"MD":1.5,"NVIW.SI":0.6,"QLD":0.6,"GSK":1.5,"PSQ":0.6,".IXIC":1.5,"NQmain":0.6,"USJW.SI":0.6},"content_text":"Austin, Texas, United States, January 8th, 2026, FinanceWire LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collabo...","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}